Everything below concerns anti-doping testing. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-31. Where a claim depends on a specific study, the study is described rather than over-claimed.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
=== Ubiquitination of non-protein substrates === Although ubiquitination was historically considered a protein-specific post-translational modification, recent studies have shown that ubiquitin can also be conjugated to certain non-protein molecules. These include lipopolysaccharides (LPS), phospholipids and other metabolites. A notable example is the E3 ligase RNF213 which can attach ubiquitin to the lipid A moiety of bacterial LPS, promoting xenophagic clearance of invading bacteria. These findings expand the known scope of ubiquitin signaling beyond classical post-translational protein modification.
=== Europe === France abolished slavery in 1794 during the Revolution, but it was restored in 1802 under Napoleon. It has been asserted that, before the Revolution, slavery was illegal in metropolitan France (as opposed to its colonies), but this has been refuted. One of the most significant milestones in the campaign to abolish slavery throughout the world occurred in England in 1772, with British Judge Lord Mansfield, whose opinion in Somersett's Case was widely taken to have held that slavery was illegal in England. This judgement also laid down the principle that slavery contracted in other jurisdictions could not be enforced in England. The last person to be deemed a slave in a British court was Bell (Belinda) who was transported to the Americas in 1772 as a "slave for life" by a Perth court. Sons of Africa was a late 18th-century British group that campaigned to end slavery. Its members were Africans in London, freed slaves who included Ottobah Cugoano, Olaudah Equiano and other leading members of London's black community. It was closely connected to the Society for Effecting the Abolition of the Slave Trade, a non-denominational group founded in 1787, whose members included Thomas Clarkson. British Member of Parliament William Wilberforce led the anti-slavery movement in the United Kingdom, although the groundwork was an anti-slavery essay by Clarkson. Wilberforce was urged by his close friend, Prime Minister William Pitt the Younger, to make the issue his own and was also given support by reformed Evangelical John Newton.
== Aquaculture == Thailand was the world's tenth ranked aquaculture producer in 2015, having produced 0.9 million tonnes. Other ASEAN nations among the top ten were ranked: Indonesia, 3; Vietnam, 4; Myanmar, 9.
Sources: en.wikipedia.org
=== Bibliography === Helfman, G.; Collette, B. B.; Facey, D. E.; Bowen, B. W. (2009). The Diversity of Fishes: Biology, Evolution, and Ecology (PDF) (2nd ed.). Wiley-Blackwell. ISBN 978-1-4051-2494-2. Archived from the original (PDF) on 26 April 2021. Retrieved 18 January 2016. Wootton, Robert J.; Smith, Carl (2014). Reproductive Biology of Teleost Fishes. Wiley. ISBN 978-1-118-89139-1.
== Management == The treatment of obstructive sleep apnea is different from that of central sleep apnea. Treatment often starts with behavioral therapy and some people may be suggested to try a continuous positive airway pressure (CPAP) device. Many people are told to avoid alcohol, sleeping pills, and other sedatives, which can relax throat muscles, contributing to the collapse of the airway at night. The evidence supporting one treatment option compared to another for a particular person is not clear.
==== Denial of cardiovascular health claims ==== In 2001, the U.S. Food and Drug Administration rejected proposed health claims for vitamin E and cardiovascular health. The U.S. National Institutes of Health reviewed literature published up to 2008 and concluded "In general, clinical trials have not provided evidence that routine use of vitamin E supplements prevents cardiovascular disease or reduces its morbidity and mortality." The European Food Safety Authority (EFSA) reviews proposed health claims for the European Union countries. In 2010, the EFSA reviewed and rejected claims that a cause and effect relationship has been established between the dietary intake of vitamin E and maintenance of normal cardiac function or of normal blood circulation.
=== Queen's Police Medal (QPM) === England and Wales Anthony Richard Bayliss, Detective Superintendent, Warwickshire Constabulary. Frank Joseph Breen, Detective Constable, Thames Valley Police. Michael Briggs, Commander, Metropolitan Police. Eileen Margaret Eggington, Detective Chief Superintendent, Metropolitan Police. Christopher Fox, Assistant Chief Constable (designated), Warwickshire Constabulary. William Griffiths, Commander, Metropolitan Police. Gareth Jones, lately Detective Superintendent, North Wales Police. David Robertson Kenworthy, Assistant Chief Constable (designated), Avon and Somerset Constabulary. Paul Joseph Scott-Lee, Assistant Chief Constable (designated), Suffolk Constabulary. Roger John Manning, Chief Superintendent, Staffordshire Police. Graham Moore, Assistant Chief Constable (designated), Cambridgeshire Constabulary. Terence Raymond Nicholls, Constable, Metropolitan Police. Robin Edgar Norman Oake, Chief Constable, Isle of Man Constabulary. Peter John Picken, Superintendent (Divisional Commander), West Mercia Constabulary. Colin Potts, Chief Inspector (Divisional Commander), Greater Manchester Police. Gordon Michael Rogers, lately Chief Superintendent, Wiltshire Constabulary. Roger Edward Sandall, Chief Superintendent (Divisional Commander), Norfolk Constabulary. Richard Owen Thomas, Assistant Chief Constable (designated), Gwent Constabulary. Scotland Andrew Gibson Brown, Assistant Chief Constable, Lothian and Borders Police. John Orr, , Chief Constable, Strathclyde Police. William Rae, Chief Constable, Dumfries and Galloway Constabulary.
Sources: en.wikipedia.org
The increase in γGCS causes an increased production of arsenite triglutathionine (As(SG)3) an important adduct that is taken up by either multidrug associated protein 1 (MRP1) or MRP2 which remove the arsenic out of the cell and into bile for excretion. This adduct can also decompose back into inorganic arsenic. Of particular note in the excretion of arsenic is the multiple methylation steps that take place which may increase the toxicity of arsenic due to MMeAsIII being a potent inhibitor of glutathione peroxidase, glutathione reductase, pyruvate dehydrogenase, and thioredoxin reductase.
Explorers, traders and missionaries arrived from Russia beginning in 1741. In 1741 the Russian government sent Vitus Bering, a Danish-born Russian, and Aleksei Chirikov, a Russian, in the ships Saint Peter and Saint Paul on a voyage of discovery in the Northern Pacific. After the ships were separated by a storm; Chirikov discovered several eastern islands of the Aleutian group, and Bering discovered several of the western islands. Bering was shipwrecked and died in the Komandorski Islands (Commander Islands); one of which now bears his name (Bering Island), along with the surrounding Bering Sea. The survivors of Bering's party reached the Kamchatka Peninsula in a boat constructed from the wreckage of their ship, and reported the islands were rich in fur-bearing animals. Siberian fur hunters flocked to the Commander Islands and gradually moved eastward across the Aleutian Islands to North America. In this manner, Russia gained a foothold on the northwestern coast of North America. The Aleutian Islands consequently belonged to Russia, until that country transferred all its possessions in North America to the U.S. in the 1867 Alaska Purchase. In the 1780s Russian merchant and seafarer Grigory Shelikhov established a company based on the systematic exploitation of the indigenous peoples, with whom there was sporadic conflict with the native population, for example the Awa'uq Massacre.
== Medical relevance == Genetic PGLYRP2 variants or changed expression of PGLYRP2 are associated with some diseases. Patients with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, have significantly more frequent missense variants in PGLYRP2 gene (and also in the other three PGLYRP genes) than healthy controls. These results suggest that PGLYRP2 protects humans from these inflammatory diseases, and that mutations in PGLYRP2 gene are among the genetic factors predisposing to these diseases. PGLYRP2 variants are also associated with esophageal squamous cell carcinoma and Parkinson's disease. Increased serum PGLYRP2 levels are present in patients with systemic lupus erythematosus (and correlate with disease activity index, renal damage, and abnormal lipid profile), chronic hepatitis B virus infection, myocardial infarction, and coronary artery disease (and correlate with the severity of the disease). Decreased expression of PGLYRP2 is found in HIV-associated tuberculosis, drug-sensitive tuberculosis, Lyme disease, hepatocellular carcinoma, and polyarteritis nodosa. Autoantibodies to PGLYRP2 are significantly increased in patients with rheumatoid arthritis.
is the ideal gas constant. The relationships between the state variables described in this equation are a good approximation of the behavior of many gases under a wide range of conditions, though there are some limitations.
Of the world's 500 largest companies by revenue, 138 were headquartered in the U.S. in 2025, the highest number of any country. The U.S. dollar is the currency most used in international transactions and the world's foremost reserve currency, backed by the country's dominant economy, its military, the petrodollar system, its large U.S. treasuries market, and its linked eurodollar. Several countries use it as their official currency, and in others it is the de facto currency. The U.S. has free trade agreements with several countries, including the USMCA. Although the United States has reached a post-industrial level of economic development and is often described as having a service economy, it remains a major industrial power; in 2024, the U.S. manufacturing sector was the world's second-largest by value output after China's.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.